BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
340 results:

  • 1. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.
    Bibbò F; Asadzadeh F; Boccia A; Sorice C; Bianco O; Saccà CD; Majello B; Donofrio V; Bifano D; De Martino L; Quaglietta L; Cristofano A; Covelli EM; Cinalli G; Ferrucci V; De Antonellis P; Zollo M
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the pten/PI3K/AKT/NF-κB pathway.
    Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
    Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
    Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
    Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. nSEA: n-Node Subnetwork Enumeration Algorithm Identifies Lower Grade Glioma Subtypes with Altered Subnetworks and Distinct Prognostics.
    Zhang Z; Wang C; Zhao Z; Yi Z; Durmaz A; Yu JS; Bebek G
    Pac Symp Biocomput; 2024; 29():521-533. PubMed ID: 38160304
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. pten-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells.
    Wang S; Riedstra CP; Zhang Y; Anandh S; Dudley AC
    Br J Cancer; 2024 Mar; 130(4):555-567. PubMed ID: 38148377
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules.
    Iragavarapu-Charyulu V; Shakya R; Robinson P; Guzmán E; Tyulmenkova A; Pino JL; Isgor C
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131223
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
    Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
    Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.
    Olatunji G; Aderinto N; Adefusi T; Kokori E; Akinmoju O; Yusuf I; Olusakin T; Muzammil MA
    Medicine (Baltimore); 2023 Dec; 102(48):e36421. PubMed ID: 38050252
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line treatment of Advanced Gastric cancer: K-Umbrella Gastric cancer Study.
    Lee CK; Kim HS; Jung M; Kim H; Bae WK; Koo DH; Jeung HC; Park SR; Hwang IG; Zang DY; Lee HW; Park S; Nam CM; Chung HC; Rha SY
    J Clin Oncol; 2024 Jan; 42(3):348-357. PubMed ID: 37883723
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma treatment.
    Singh S; Barik D; Lawrie K; Mohapatra I; Prasad S; Naqvi AR; Singh A; Singh G
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834408
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
    Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
    Li YQ; Sun FZ; Li CX; Mo HN; Zhou YT; Lv D; Zhai JT; Qian HL; Ma F
    Mil Med Res; 2023 Jul; 10(1):34. PubMed ID: 37491281
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nicotinamide Adenine Dinucleotide Phosphate Oxidase Promotes Glioblastoma Radiation Resistance in a Phosphate and Tensin Homolog-Dependent Manner.
    Ludwig K; Le Belle JE; Muthukrishnan SD; Sperry J; Condro M; Vlashi E; Pajonk F; Kornblum HI
    Antioxid Redox Signal; 2023 Nov; 39(13-15):890-903. PubMed ID: 37470216
    [No Abstract]    [Full Text] [Related]  

  • 16. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial.
    Cappelli L; Khan MM; Kayne A; Poiset S; Miller R; Ali A; Niazi M; Shi W; Alnahhas I
    Chin Clin Oncol; 2023 Jun; 12(3):23. PubMed ID: 37417289
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Upstream open reading frame-encoded MP31 disrupts the mitochondrial quality control process and inhibits tumorigenesis in glioblastoma.
    Huang N; Chen Z; Yang X; Gao Y; Zhong J; Li Y; Xiao F; Wang X; Shi Y; Zhang N
    Neuro Oncol; 2023 Nov; 25(11):1947-1962. PubMed ID: 37280112
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Redefining Autoimmune Disorders' Pathoetiology: Implications for Mood and Psychotic Disorders' Association with Neurodegenerative and Classical Autoimmune Disorders.
    Anderson G; Almulla AF; Reiter RJ; Maes M
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174637
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors.
    Lazzarini E; Silvestris DA; Benvenuto G; Osti D; Fattore L; Paterra R; Finocchiaro G; Malatesta P; Daga A; Gallotti AL; Galli R; Pelicci G; Tesei A; Bedeschi M; Pallini R; Pasqualini L; Romualdi C; Gallo A; Ricci-Vitiani L; Indraccolo S
    J Neurooncol; 2023 May; 163(1):47-59. PubMed ID: 37140883
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Very long-term survival of an older glioblastoma patient after treatment with cilengitide: a case report.
    Alalami H; Bannykh S; Fan X; Hu J
    CNS Oncol; 2023 Jun; 12(2):CNS96. PubMed ID: 37092563
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.